First-of-its-kind Aurora EV-ICD™ system offers single device, single procedure with lead placed outside of heart and veins FDA approval of the Medtronic Aurora EV-ICD system includes the system's ...

Background Cardiac surgery carries a heightened risk of bradyarrhythmias, but current permanent pacemaker (PPM) implantation ...

Implantable cardioverter-defibrillators (ICDs) have become standard therapy in patients at high risk for sudden death. [1,2] but their disadvantages, such as failure of the transvenous leads, ...

The US FDA study is intended to evaluate the system for treating life-threatening ventricular tachyarrhythmias.

CINCINNATI (WKRC) -Local doctors are among the first in the nation to use a new, implantable device to help save lives. It helps keep the heart beating strong. This new device could help reduce the ...

Background: Unlike the tremendous progress made in atrial fibrillation ablation, the greatest unmet clinical need is for innovative ablation treatments for scar-related ventricular tachycardia (VT) – ...

Atrium Health Sanger Heart & Vascular Institute cardiology team perform surgery on a patient with heart valve disease, using a newly, FDA-approved clip device. The device gives patients diagnosed with ...

In June, Advocate Lutheran General Hospital in Park Ridge began offering a new option to heart patients with leaky tricuspid heart valves, a condition that doctors previously had few tools to treat.

SEOUL, South Korea, April 16, 2025 /PRNewswire/ -- Mezzion Pharmaceuticals, a global leader in the development of therapies for patients with single ventricle heart disease, announces a transformative ...